Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Coagulation Disorders, Inherited: early-phase trial registry
1 of 3 indexed Blood Coagulation Disorders, Inherited trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Blood Coagulation Disorders, Inherited: 3 US clinical trials tracked, 1 recruiting.
Blood Coagulation Disorders, Inherited is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Spur Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition blood-coagulation-disorders-inherited
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Blood Coagulation Disorders, Inherited lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blood Coagulation Disorders, Inherited on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blood Coagulation Disorders, Inherited is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
The University of Texas Health Science Center, Houston
NCT00178594
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
Spur Therapeutics
NCT04272554
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Spark Therapeutics
NCT03734588
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Blood Coagulation Disorders, Inherited records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blood Coagulation Disorders, Inherited trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blood Coagulation Disorders, Inherited page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Blood Coagulation Disorders, Inherited trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Spur Therapeutics sponsors the most Blood Coagulation Disorders, Inherited trials on record, review their full trial history before evaluating a specific study. See Spur Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Coagulation Disorders, Inherited condition card totals 3 registered trials; most-linked intervention SPK-8016; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.